The global antimicrobial susceptibility tester market size is poised for substantial growth, expected to reach a valuation of US$ 6.37 billion by 2032, up from US$ 3.7 billion in 2022. The market is anticipated to register a CAGR of 5.6% during the 2022-2032 forecast period. The growing threat of bacterial, viral, fungal, and other microbial mutations is a significant challenge to modern medical technology, necessitating the development of more effective medications, antibiotics, and immune boosters.
The global antimicrobial susceptibility tester market is set for significant growth over the next decade, driven by technological advancements, rising infection rates, and increased focus on drug discovery. With North America leading the market and APAC emerging as a lucrative region, the future looks promising for industry players and stakeholders.
Click Here to Request Your Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-8497
Key Takeaways
- Market Growth: The antimicrobial susceptibility tester market is projected to grow from US$ 3.7 billion in 2022 to US$ 6.37 billion by 2032, registering a CAGR of 5.6%.
- Technological Advancements: Continuous improvements in antimicrobial susceptibility testers are enhancing their accuracy and reliability, driving market demand.
- Rising Infections: The increasing frequency of outbreaks caused by infectious organisms, including tuberculosis, HIV, and malaria, is boosting the demand for antimicrobial susceptibility testing kits.
- Drug Discovery Focus: The rise in drug discovery, emergence of new diseases, and increasing incidences of chronic disorders and antimicrobial resistance (AMR) are propelling the market.
- Regional Insights: North America leads the market due to high infection rates, safety concerns, and technological advancements, while the Asia-Pacific region is emerging as a lucrative market due to improved healthcare infrastructure and rising infection rates.
Market Drivers
The growing incidence of infections caused by organisms such as Haemophilus influenzae, Streptococcus pneumoniae, and Salmonella serotype Typhi is driving the demand for antimicrobial susceptibility testing kits. According to the World Health Organization, tuberculosis remains one of the top ten causes of death globally, with 10 million cases reported in 2018 and 1.5 million deaths. Similarly, the Joint United Nations Programme on HIV/AIDS (UNAIDS) reported 1.7 million new HIV infections and 690,000 AIDS-related deaths in 2019. The World Malaria Report 2019 estimated 228 million malaria cases worldwide, with 85% of the global malaria burden concentrated in Sub-Saharan Africa and India.
Technological Innovations
Antimicrobial susceptibility testers are increasingly being used in hospitals, laboratories, and research settings to evaluate the effectiveness of antibiotics against various microorganisms. The ability of these devices to measure the refractive index and the thickness of thin transparent films to the smallest unit, such as 1nm, has positioned ellipsometry as a crucial technology in the market. Manufacturers are continuously innovating to provide the most reliable products, further driving market growth.
Contact Sales for Further Assistance in Purchasing this Report! https://www.futuremarketinsights.com/checkout/8497
Regional Analysis
North America: In 2021, North America held the largest share of the antimicrobial susceptibility tester market. Factors such as the high prevalence of infectious diseases, stringent safety regulations, and technological advancements are driving market growth in the region. Major companies like Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, and Bruker Corporation have a significant presence in North America, contributing to market expansion.
The rapid availability of information on bacterial infections and antibiotic susceptibility facilitates the timely adoption of appropriate treatment therapies, playing a crucial role in disease management and driving demand in North America.
Asia-Pacific (APAC): The APAC region is projected to be a lucrative market for antimicrobial susceptibility testers. The increasing incidence of infectious diseases, epidemic and pandemic occurrences, and rising adoption of antimicrobial susceptibility testing are key factors driving market growth. The innovation of manual and automated products that provide accurate and timely results is creating significant opportunities for market players.
Improved healthcare infrastructure, rising healthcare demands, and the growing prevalence of antibiotic resistance are further propelling market growth in APAC. Leading industry players are increasingly investing in the region to capitalize on the growing potential of the antimicrobial susceptibility testing market.
Market Competition
Beckman Coulter, Inc., ThermoFisher Scientific Inc., HiMedia Laboratories, Becton, Dickinson and Company, Creative Diagnostics, MERLIN, Alifax, Bioanalyse, bioMerieux are among the top players of antimicrobial susceptibility testers market.
Key Segments Profiled in the Global Antimicrobial Susceptibility Tester Market
By Equipment Type:
- Laser antimicrobial susceptibility tester
- Spectroscopic antimicrobial susceptibility tester
By Application:
- Automatic antimicrobial susceptibility testers
- Manual antimicrobial susceptibility testers
- Custom antimicrobial susceptibility testers
- Antimicrobial susceptibility tester for MIC strips
- Susceptibility plates, and
- Other
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube